Summary & Overview
HCPCS Level II J2950: Injection of Promazine HCl, Up to 25 mg
HCPCS Level II code J2950 denotes an injectable dose of promazine hydrochloride up to 25 mg. This code captures administration of a phenothiazine-class antipsychotic used in certain behavioral health and psychiatric contexts. Nationally, accurate reporting of J2950 is important for tracking medication utilization, ensuring appropriate billing, and supporting quality monitoring for injectable psychotropic therapy.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code's clinical context, typical sites of service, and common billing practices. The publication outlines benchmarks and coverage patterns across major payers, highlights relevant coding considerations, and summarizes any recent policy or reimbursement updates when available.
The document provides practical reference material for revenue cycle teams, billing staff, and clinical administrators who manage injectable medication services. It clarifies the service represented by J2950, what settings commonly use this code, and where to look for payer-specific coverage guidance. Data not available in the input will be noted where applicable.
Billing Code Overview
HCPCS Level II code J2950 represents an injection of promazine hydrochloride, up to 25 mg. This code is used to report administration of promazine HCl as a single injectable medication dose. The service type is medication administration (injectable antipsychotic/phenothiazine). The typical site of service includes outpatient clinics, physician offices, behavioral health clinics, and other ambulatory care settings where injectable psychotropic medications are administered.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with agitation, psychosis, or severe nausea requiring intramuscular antipsychotic or antiemetic control where promazine HCl is indicated. A patient may present to the emergency department or outpatient behavioral health clinic with acute agitation related to schizophrenia, bipolar mania, severe alcohol withdrawal, or chemotherapy-induced intractable nausea. After triage and assessment by a licensed clinician (emergency physician, psychiatrist, or advanced practice provider), informed consent is obtained when possible and baseline vitals and allergic history are reviewed. The medication is prepared in a single-dose syringe and administered as an intramuscular injection, typically in the deltoid or gluteal muscle, with post-injection monitoring for sedation, hypotension, extrapyramidal symptoms, and respiratory depression. Documentation includes indication, dose, site, route, lot number, patient response, and any adverse events. Billing uses HCPCS Level II code J2950 for the promazine HCl injection unit, with appropriate modifiers for circumstances such as unanticipated services, reduced services, or if provided in an ambulatory surgery center.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier information | Rarely used; indicates no special modifier applies |